Biostage Program Organ Regeneration

Share this article with:

About 456,000 new cases of esophageal cancer occur each year. In the United States alone, there are 17,000 new cases. Esophageal cancer is treated with an esophagectomy, which has a 90-day mortality rate as high as 19%. Biostage is pioneering a new technology to regenerate the patient’s native esophasgus through Cellframe Technology. Two weeks before the esophagectomy, stem cells are extract and incubated with the Cellspan implant in a bioreactor. This animation shows how Cellframe Technology works to regenerate esophagus tissue and muscle through stem cells as well as the Cellspan Implant process.

Share It:
Contact XVIVO


Biostage Program Organ Regeneration

The feedback from the client was all very positive. I want to thank the XVIVO team for a job well done. Our work with the client’s clinical team up front paid off on the back end with minimal revisions and I want to thank you guys for your patience and hard work.

Vice President | Creative Director, The Navicor Group, LLC